{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:27:06Z","timestamp":1792524426553,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bronchiectasis is a heterogeneous disease depending on etiology. It represents the most frequent non-infectious pulmonary complication of primary immunodeficiencies (PID). We investigated whether bronchiectasis associated with PID had a distinct course in comparison to bronchiectasis of other causes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective single-center study of adult patients diagnosed with non-cystic fibrosis bronchiectasis with more than 5\u2009years of follow-up and at least 4 pulmonary functional tests available at one year apart. They were divided into three groups: PID- related bronchiectasis, idiopathic\/post infectious-related bronchiectasis and other causes of bronchiectasis. Respiratory functional data and clinical outcomes were compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 329 patients with bronchiectasis diagnosed in Foch Hospital (Suresnes, France), 98 patients fulfilled the selected criteria (20 PID-related cases, 39 idiopathic or post-infectious cases, and 39 cases with other causes). Median time of follow-up was 9.5\u2009years. Groups were similar concerning initial characteristics (female 70.4%, never smokers 59.2%, mild severity bronchiectasis according to the FACED score and median FEV1 at diagnosis 73.5% predicted values [Q1\u2013Q3: 53.75\u201390.5]), except PID patients who were younger (median age of 51.5 vs 62\u2009years,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.02). Eighty-five percent of PID patients received immunoglobulin substitution (median trough level was measured at 10.5\u2009g\/dl [10;10.92]). Global median FEV1 annual decline was 25.03\u2009ml\/year [8.16;43.9] and 19.82\u2009ml\/year [16.08;48.02] in the PID patients group. Forty-five percent of patients had bacterial colonization, pneumoniae occurred in 56% of patients and median exacerbation annual rate was 0.8 [0.3\u20131.4]. Hemoptysis occurred in 31.6% of patients. Global mortality rate was 11.2%. We did not record any significant difference for all clinical and functional outcomes between patients with PID and other etiologies. The median decline in FEV1 was similar in the three groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The course of PID-related bronchiectasis was similar to bronchiectasis of other causes. Provided that patients receive immunoglobulin replacement, the course of PID-related bronchiectasis seems to be independent of the underlying immune disorder.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-019-1242-4","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T14:03:28Z","timestamp":1575468208000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Primary immunodeficiency-related bronchiectasis in adults: comparison with bronchiectasis of other etiologies in a French reference center"],"prefix":"10.1186","volume":"20","author":[{"given":"H\u00e9l\u00e8ne","family":"Goussault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9294-5340","authenticated-orcid":false,"given":"H\u00e9l\u00e8ne","family":"Salvator","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Catherinot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Chabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colas","family":"Tcherakian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Chabrol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Didier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Rivaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Lanternier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar","family":"Mahlaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Devillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis-Jean","family":"Couderc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,4]]},"reference":[{"issue":"4","key":"1242_CR1","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1164\/ajrccm.162.4.9906120","volume":"162","author":"MC Pasteur","year":"2000","unstructured":"Pasteur MC, Helliwell SM, Houghton SJ, Webb SC, Foweraker JE, Coulden RA, et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med. 2000;162(4):1277\u201384.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"1242_CR2","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.rmed.2006.11.008","volume":"101","author":"A Shoemark","year":"2007","unstructured":"Shoemark A, Ozerovitch L, Wilson R. Aetiology in adult patients with bronchiectasis. Respir Med. 2007;101(6):1163\u201370.","journal-title":"Respir Med"},{"issue":"1","key":"1242_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1378\/chest.11-1024","volume":"142","author":"PJ McShane","year":"2012","unstructured":"McShane PJ, Naureckas ET, Strek ME. Bronchiectasis in a diverse US population. Chest. 2012;142(1):159\u201367.","journal-title":"Chest"},{"issue":"7","key":"1242_CR4","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.rmed.2013.04.013","volume":"107","author":"GA Anwar","year":"2013","unstructured":"Anwar GA, McDonnell MJ, Worthy SA, Bourke SC, Afolabi G, Lordan J, et al. Phenotyping adults with non-cystic fibrosis bronchiectasis: a prospective observational cohort study. Respir Med. 2013;107(7):1001\u20137.","journal-title":"Respir Med"},{"issue":"12","key":"1242_CR5","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1513\/AnnalsATS.201507-472OC","volume":"12","author":"S Lonni","year":"2015","unstructured":"Lonni S, Chalmers JD, Goeminne PC, McDonnell MJ, Dimakou K, De Soyza A, et al. Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity. Ann Am Thorac Soc. 2015;12(12):1764\u201370.","journal-title":"Ann Am Thorac Soc"},{"issue":"12","key":"1242_CR6","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/j.rmed.2006.03.012","volume":"100","author":"PT King","year":"2006","unstructured":"King PT, Holdsworth SR, Freezer NJ, et al. Characterisation of the onset and presenting clinical features of adult bronchiectasis. Respir Med. 2006;100(12):2183\u20139.","journal-title":"Respir Med"},{"issue":"1","key":"1242_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.clim.2010.06.012","volume":"137","author":"JS Orange","year":"2010","unstructured":"Orange JS, Grossman WJ, Navickis RJ, et al. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies. Clin Immunol. 2010;137(1):21\u201330.","journal-title":"Clin Immunol"},{"issue":"2","key":"1242_CR8","first-page":"114","volume":"39","author":"Z Pourpak","year":"2006","unstructured":"Pourpak Z, Aghamohammadi A, Sedighipour L, Farhoudi A, Movahedi M, Gharagozlou M, et al. Effect of regular intravenous immunoglobulin therapy on prevention of pneumonia in patients with common variable immunodeficiency. J Microbiol Immunol Infect. 2006;39(2):114\u201320.","journal-title":"J Microbiol Immunol Infect"},{"issue":"10","key":"1242_CR9","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/cid\/ciu646","volume":"59","author":"C Aguilar","year":"2014","unstructured":"Aguilar C, Malphettes M, Donadieu J, Chandesris O, Coignard-Biehler H, Catherinot E, et al. Prevention of Infections During Primary Immunodeficiency. Clin Infect Dis. 2014;59(10):1462\u201370.","journal-title":"Clin Infect Dis"},{"key":"1242_CR10","doi-asserted-by":"publisher","first-page":"A1334","DOI":"10.1164\/rccm.201602-0269ED","volume":"193","author":"M Didier","year":"2016","unstructured":"Didier M, Mahlaoui N, Oksenhender E. Pulmonary manifestations in adult patients with primary predominantly humoral immune deficiencies: a Paris area reference network study. Am J Respir Crit Care Med. 2016;193:A1334.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1242_CR11","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","volume":"134","author":"B Gathmann","year":"2014","unstructured":"Gathmann B, Mahlaoui N, G\u00e9rard L, Oksenhendler E, Warnatz K, Schulze I, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;134(1):116\u2013126.e11.","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"1242_CR12","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1086\/587669","volume":"46","author":"E Oksenhendler","year":"2008","unstructured":"Oksenhendler E, G\u00e9rard L, Fieschi C, Malphettes M, Mouillot G, Jaussaud R, et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis. 2008;46(10):1547\u201354.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1242_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1006\/clim.1999.4725","volume":"92","author":"C Cunningham-Rundles","year":"1999","unstructured":"Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92(1):34\u201348.","journal-title":"Clin Immunol"},{"issue":"2","key":"1242_CR14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.rmed.2013.12.015","volume":"108","author":"PC Goeminne","year":"2014","unstructured":"Goeminne PC, Nawrot TS, Ruttens D, et al. Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis. Respir Med. 2014;108(2):287\u201396.","journal-title":"Respir Med"},{"issue":"5","key":"1242_CR15","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1378\/chest.07-0490","volume":"132","author":"MA Mart\u00ednez-Garc\u00eda","year":"2007","unstructured":"Mart\u00ednez-Garc\u00eda MA, Soler-Catalu\u00f1a J-J, Perpi\u00f1\u00e1-Tordera M, et al. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest. 2007;132(5):1565\u201372.","journal-title":"Chest"},{"issue":"Suppl 1","key":"1242_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/thoraxjnl-2018-212463","volume":"74","author":"AT Hill","year":"2019","unstructured":"Hill AT, Sullivan AL, Chalmers JD, De Soyza A, Stuart EJ, Floto AR, et al. British thoracic society guideline for bronchiectasis in adults. Thorax. 2019;74(Suppl 1):1\u201369.","journal-title":"Thorax"},{"issue":"5","key":"1242_CR17","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1183\/09031936.00026313","volume":"43","author":"MA Martinez-Garcia","year":"2014","unstructured":"Martinez-Garcia MA, de Gracia J, Vendrell Relat M, Giron R-M, Maiz Carro L, de la Rosa CD, et al. Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score. Eur Respir J. 2014;43(5):1357\u201367.","journal-title":"Eur Respir J"},{"issue":"3","key":"1242_CR18","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1148\/radiology.179.3.2027992","volume":"179","author":"M Bhalla","year":"1991","unstructured":"Bhalla M, Turcios N, Aponte V, Jenkins M, Leitman BS, McCauley DI, et al. Cystic fibrosis: scoring system with thin-section CT. Radiology. 1991;179(3):783\u20138.","journal-title":"Radiology"},{"issue":"4","key":"1242_CR19","doi-asserted-by":"publisher","first-page":"S525","DOI":"10.1016\/j.jaci.2006.01.015","volume":"117","author":"J Orange","year":"2006","unstructured":"Orange J, Hossny E, Weiler C, Ballow M, Berger M, Bonilla F, et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the primary immunodeficiency Committee of the American Academy of allergy, asthma and immunology. J Allergy Clin Immunol. 2006;117(4):S525\u201353.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1242_CR20","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1183\/09031936.00003709","volume":"34","author":"MR Loebinger","year":"2009","unstructured":"Loebinger MR, Wells AU, Hansell DM, Chinyanganya N, Devaraj A, Meister M, et al. Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J. 2009;34(4):843\u20139.","journal-title":"Eur Respir J"},{"issue":"6","key":"1242_CR21","first-page":"643","volume":"100","author":"GE Lindskog","year":"1955","unstructured":"Lindskog GE, Hubbell DS. An analysis of 215 cases of bronchiectasis. Surg Gynecol Obstet. 1955;100(6):643\u201350.","journal-title":"Surg Gynecol Obstet"},{"issue":"Suppl 165","key":"1242_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1651-2227.1966.tb14958.x","volume":"55","author":"EM Glauser","year":"1966","unstructured":"Glauser EM, Cook CD, Harris GB. Bronchiectasis: a review of 187 cases in children with follow-up pulmonary function studies in 58. Acta Paediatr Scand. 1966;55(Suppl 165):3\u201316.","journal-title":"Acta Paediatr Scand"},{"issue":"3","key":"1242_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1136\/thx.29.3.304","volume":"29","author":"LI Landau","year":"1974","unstructured":"Landau LI, Phelan PD, Williams HE. Ventilatory mechanics in patients with bronchiectasis starting in childhood. Thorax. 1974;29(3):304\u201312.","journal-title":"Thorax"},{"issue":"3","key":"1242_CR24","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jaci.2011.09.047","volume":"129","author":"R Micol","year":"2012","unstructured":"Micol R, Kayal S, Mahlaoui N, Beaut\u00e9 J, Brosselin P, Dudoit Y, et al. Protective effect of IgM against colonization of the respiratory tract by nontypeable Haemophilus influenzae in patients with hypogammaglobulinemia. J Allergy Clin Immunol. 2012;129(3):770\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"1242_CR25","first-page":"A4744","volume":"195","author":"E Catherinot","year":"2017","unstructured":"Catherinot E, Givel C, Chandesris O, et al. Pulmonary manifestations in adult patients with STAT3 deficiency: a French nationwide registry-based cohort study [abstract]. Am J Respir Crit Care Med. 2017;195:A4744.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"1242_CR26","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jaci.2009.10.059","volume":"125","author":"C Woellner","year":"2010","unstructured":"Woellner C, Gertz EM, Sch\u00e4ffer AA, Lagos M, Perro M, Glocker E-O, et al. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol. 2010;125(2):424\u2013432.e8.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1242_CR27","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1183\/09031936.00118414","volume":"45","author":"H Salvator","year":"2015","unstructured":"Salvator H, Mahlaoui N, Catherinot E, Rivaud E, Pilmis B, Borie R, et al. Pulmonary manifestations in adult patients with chronic granulomatous disease. Eur Respir J. 2015;45(6):1613\u201323.","journal-title":"Eur Respir J"},{"issue":"1","key":"1242_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jaip.2017.05.024","volume":"6","author":"JM Sperlich","year":"2018","unstructured":"Sperlich JM, Grimbacher B, Workman S, Haque T, Seneviratne SL, Burns SO, et al. Respiratory Infections and Antibiotic Usage in Common Variable Immunodeficiency. J Allergy Clin Immunol Pract. 2018;6(1):159\u2013168.e3.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"1242_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000446923","volume":"92","author":"M Buscot","year":"2016","unstructured":"Buscot M, Pottier H, Marquette C-H, Leroy S. Phenotyping adults with non-cystic fibrosis bronchiectasis: a 10-year cohort study in a French Regional University hospital center. Respiration. 2016;92(1):1\u20138.","journal-title":"Respiration"},{"issue":"6","key":"1242_CR30","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.jaci.2011.03.041","volume":"127","author":"Y Chen","year":"2011","unstructured":"Chen Y, Stirling RG, Paul E, Hore-Lacy F, Thompson BR, Douglass JA. Longitudinal decline in lung function in patients with primary immunoglobulin deficiencies. J Allergy Clin Immunol. 2011;127(6):1414\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1242_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s10875-013-9942-x","volume":"34","author":"JR Hurst","year":"2014","unstructured":"Hurst JR, Workman S, Garcha DS, Seneviratne SL, Haddock JA, Grimbacher B. Activity, severity and impact of respiratory disease in primary antibody deficiency syndromes. J Clin Immunol. 2014;34(1):68\u201375.","journal-title":"J Clin Immunol"},{"issue":"6","key":"1242_CR32","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.intimp.2004.02.011","volume":"4","author":"J de Gracia","year":"2004","unstructured":"de Gracia J, Vendrell M, Alvarez A, Pallisa E, Rodrigo M-J, de la Rosa D, et al. Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency. Int Immunopharmacol. 2004;4(6):745\u201353.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"1242_CR33","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.jaci.2010.02.040","volume":"125","author":"M Lucas","year":"2010","unstructured":"Lucas M, Lee M, Lortan J, Lopez-Granados E, Misbah S, Chapel H. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol. 2010;125(6):1354\u20131360.e4.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1242_CR34","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jaci.2008.04.044","volume":"122","author":"VR Bonagura","year":"2008","unstructured":"Bonagura VR, Marchlewski R, Cox A, Rosenthal DW. Biologic IgG level in primary immunodeficiency disease: the IgG level that protects against recurrent infection. J Allergy Clin Immunol. 2008;122(1):210\u20132.","journal-title":"J Allergy Clin Immunol"},{"issue":"9842","key":"1242_CR35","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","volume":"380","author":"C Wong","year":"2012","unstructured":"Wong C, Jayaram L, Karalus N, Eaton T, Tong C, Hockey H, et al. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. Lancet Lond Engl. 2012;380(9842):660\u20137.","journal-title":"Lancet Lond Engl"},{"issue":"12","key":"1242_CR36","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1001\/jama.2013.1937","volume":"309","author":"J Altenburg","year":"2013","unstructured":"Altenburg J, de Graaff CS, Stienstra Y, Sloos JH, van Haren EHJ, Koppers RJH, et al. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial. JAMA. 2013;309(12):1251\u20139.","journal-title":"JAMA"},{"issue":"1","key":"1242_CR37","first-page":"67","volume":"81","author":"J Altenburg","year":"2011","unstructured":"Altenburg J, de Graaff CS, van der Werf TS, Boersma WG. Immunomodulatory effects of macrolide antibiotics \u2013 part 1: biological mechanisms. Respir Int Rev Thorac Dis. 2011;81(1):67\u201374.","journal-title":"Respir Int Rev Thorac Dis"},{"issue":"9","key":"1242_CR38","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1111\/j.1365-2222.2012.03979.x","volume":"42","author":"EJ Cameron","year":"2012","unstructured":"Cameron EJ, McSharry C, Chaudhuri R, Farrow S, Thomson NC. Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2012;42(9):1302\u201312.","journal-title":"Clin Exp Allergy J Br Soc Allergy Clin Immunol"},{"issue":"1","key":"1242_CR39","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/jac\/dkh519","volume":"55","author":"GW Amsden","year":"2005","unstructured":"Amsden GW. Anti-inflammatory effects of macrolides \u2013 an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother. 2005;55(1):10\u201321.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"1242_CR40","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1111\/resp.12375","volume":"19","author":"AI Lourdesamy Anthony","year":"2014","unstructured":"Lourdesamy Anthony AI, Muthukumaru U. Efficacy of azithromycin in the treatment of bronchiectasis. Respirol Carlton Vic. 2014;19(8):1178\u201382.","journal-title":"Respirol Carlton Vic"},{"issue":"1","key":"1242_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1128\/AAC.00607-07","volume":"52","author":"TD Starner","year":"2008","unstructured":"Starner TD, Shrout JD, Parsek MR, Appelbaum PC, Kim G. Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and diminish established biofilms. Antimicrob Agents Chemother. 2008;52(1):137\u201345.","journal-title":"Antimicrob Agents Chemother"},{"key":"1242_CR42","unstructured":"Milito C, Pulvirenti F, Tabolli S, et al. A multicenter, double-blind, placebo-controlled randomized clinical trial on l."},{"issue":"2","key":"1242_CR43","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1136\/thoraxjnl-2015-208188","volume":"72","author":"V Navaratnam","year":"2017","unstructured":"Navaratnam V, Millett ERC, Hurst JR, Thomas SL, Smeeth L, Hubbard RB, et al. Bronchiectasis and the risk of cardiovascular disease: a population-based study. Thorax. 2017;72(2):161\u20136.","journal-title":"Thorax"},{"issue":"3","key":"1242_CR44","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1365-2249.2008.03700.x","volume":"153","author":"J Litzman","year":"2008","unstructured":"Litzman J, Freiberger T, Grimbacher B, Gathmann B, Salzer U, Pavl\u00edk T, et al. Mannose-binding lectin gene polymorphic variants predispose to the development of bronchopulmonary complications but have no influence on other clinical and laboratory symptoms or signs of common variable immunodeficiency. Clin Exp Immunol. 2008;153(3):324\u201330.","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"1242_CR45","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3109\/00365513.2013.819523","volume":"73","author":"S Gregersen","year":"2013","unstructured":"Gregersen S, Holm AM, Fevang B, Ueland T, Sikkeland LIB, Aal\u00f8kken TM, et al. Lung disease, T-cells and inflammation in common variable immunodeficiency disorders. Scand J Clin Lab Invest. 2013;73(6):514\u201322.","journal-title":"Scand J Clin Lab Invest"},{"issue":"4","key":"1242_CR46","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1513\/AnnalsATS.201310-335OC","volume":"11","author":"GB Rogers","year":"2014","unstructured":"Rogers GB, Zain NMM, Bruce KD, Burr LD, Chen AC, Rivett DW, et al. A novel microbiota stratification system predicts future exacerbations in bronchiectasis. Ann Am Thorac Soc. 2014;11(4):496\u2013503.","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"1242_CR47","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1513\/AnnalsATS.201411-513OC","volume":"12","author":"SL Taylor","year":"2015","unstructured":"Taylor SL, Rogers GB, Chen AC-H, Burr LD, McGuckin MA, Serisier DJ. Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis. Ann Am Thorac Soc. 2015;12(5):701\u20137.","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"1242_CR48","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/cei.12003","volume":"171","author":"RJ Boyton","year":"2013","unstructured":"Boyton RJ, Reynolds CJ, Quigley KJ, Altmann DM. Immune mechanisms and the impact of the disrupted lung microbiome in chronic bacterial lung infection and bronchiectasis. Clin Exp Immunol. 2013;171(2):117\u201323.","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"1242_CR49","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2213-2600(18)30053-5","volume":"6","author":"JD Chalmers","year":"2018","unstructured":"Chalmers JD, Chotirmall SH. Bronchiectasis: new therapies and new perspectives. Lancet Respir Med. 2018;6(9):715\u201326.","journal-title":"Lancet Respir Med"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-019-1242-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-019-1242-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-019-1242-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T20:32:20Z","timestamp":1606941140000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-019-1242-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1242"],"URL":"https:\/\/doi.org\/10.1186\/s12931-019-1242-4","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"30 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"275"}}